FDA chief: AI adoption driven by financial reasons, not patient benefits

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Robert Califf: Clinical care should drive AI adoption

It’s day two of the FDA’s advisory committee meeting on regulating generative artificial intelligence tools. Day one, as you might expect, was extremely technical, but it kicked off with provocative remarks from commissioner Robert Califf.

Read the rest…